2003
DOI: 10.1086/379525
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in a Gene Encoding a Novel SH3/TPR Domain Protein Cause Autosomal Recessive Charcot-Marie-Tooth Type 4C Neuropathy

Abstract: Charcot-Marie-Tooth disease type 4C (CMT4C) is a childhood-onset demyelinating form of hereditary motor and sensory neuropathy associated with an early-onset scoliosis and a distinct Schwann cell pathology. CMT4C is inherited as an autosomal recessive trait and has been mapped to a 13-cM linkage interval on chromosome 5q23-q33. By homozygosity mapping and allele-sharing analysis, we refined the CMT4C locus to a suggestive critical region of 1.7 Mb. We subsequently identified mutations in an uncharacterized tra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

7
175
0
6

Year Published

2009
2009
2019
2019

Publication Types

Select...
3
3

Relationship

3
3

Authors

Journals

citations
Cited by 180 publications
(188 citation statements)
references
References 29 publications
7
175
0
6
Order By: Relevance
“…Nerve conduction velocity measurements, morphometric analyses, and transcriptional analysis indicated the presence of the neuropathy already at 4 weeks of age, suggesting an early onset of the disease in Sh3tc2 ⌬Ex1/⌬Ex1 mice. The neuropathy was then slowly progressive; adult mutant mice presented MNCV and SNCV values Ϸ15 m/s below controls, which is a decrease comparable to the values recorded in CMT4C patients (4). Whereas CMT4C disease is commonly classified as ''demyelinating'' disease, we did not observe any signs of demyelination (e.g., myelin debris, Schwann cell onion bulbs, or macrophage infiltration) in the early stages of the disease in Sh3tc2 ⌬Ex1/⌬Ex1 mice.…”
Section: Discussionsupporting
confidence: 68%
See 4 more Smart Citations
“…Nerve conduction velocity measurements, morphometric analyses, and transcriptional analysis indicated the presence of the neuropathy already at 4 weeks of age, suggesting an early onset of the disease in Sh3tc2 ⌬Ex1/⌬Ex1 mice. The neuropathy was then slowly progressive; adult mutant mice presented MNCV and SNCV values Ϸ15 m/s below controls, which is a decrease comparable to the values recorded in CMT4C patients (4). Whereas CMT4C disease is commonly classified as ''demyelinating'' disease, we did not observe any signs of demyelination (e.g., myelin debris, Schwann cell onion bulbs, or macrophage infiltration) in the early stages of the disease in Sh3tc2 ⌬Ex1/⌬Ex1 mice.…”
Section: Discussionsupporting
confidence: 68%
“…During the last two decades, genetic studies have continuously documented new CMT4C cases (4,5,7,(12)(13)(14)(15). Although the recent identification of SH3TC2 as the gene mutated in CMT4C (4) immediately led to substantially improved clinical diagnostic and genetic counseling in the affected families, the functional role of the SH3TC2 protein in peripheral nerves remained unknown.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations